Friday, October 31, 2014 Last update: 2:33 PM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Insulet Corporation

News articles for Insulet Corporation:

Tuesday, October 21, 2014

Tuesday, September 16, 2014

Tuesday, September 2, 2014

Friday, August 15, 2014

  • Insulet Appoints Timothy J. Scannell to Board of Directors
    BEDFORD, MA -- (Marketwired) -- 08/15/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the appointment of Timothy J. Scannell to the Company's board of directors. A seasoned senior medical device executive, Mr. Scannell currently serves as ... read more

Thursday, August 7, 2014

  • Insulet Reports Second Quarter 2014 Results
    BEDFORD, MA -- (Marketwired) -- 08/07/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the three and six months ended June 30, 2014. Second Quarter Results Second quarter 2014 revenue increased 20% to $72.0 million, compared ... read more

Tuesday, August 5, 2014

  • Insulet and Dexcom Agree to Develop a CGM-Integrated Personal Diabetes Manager
    BEDFORD, MA -- (Marketwired) -- 08/05/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, and DexCom, Inc (NASDAQ: DXCM), the leader in continuous glucose monitoring ("CGM") technology, today announced their intention to allow information from Dexcom's 5th generation CGM ... read more

Friday, August 1, 2014

Tuesday, July 29, 2014

Wednesday, June 4, 2014

  • Insulet Announces Pricing of Convertible Senior Notes
    BEDFORD, MA -- (Marketwired) -- 06/04/14 -- Insulet Corporation (NASDAQ: PODD) today announced the pricing of a public offering of $175 million principal amount of convertible senior notes due 2019 (the "notes"). The notes will bear interest at an annual rate of 2.00% and will mature on June 15, ... read more

Tuesday, June 3, 2014

  • Insulet Announces Public Offering of Convertible Senior Notes
    BEDFORD, MA -- (Marketwired) -- 06/03/14 -- Insulet Corporation (NASDAQ: PODD) today announced its intention to offer, subject to market and other conditions, $175 million principal amount of convertible senior notes due 2019 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ... read more

Thursday, May 29, 2014

  • Insulet Corporation to Present at Upcoming Investor Conferences
    BEDFORD, MA -- (Marketwired) -- 05/29/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the following upcoming investor conferences: The Jefferies 2014 Global Healthcare Conference taking place June 2-5, 2014 at the Grand ... read more

Wednesday, May 7, 2014

  • Insulet Reports First Quarter 2014 Results
    BEDFORD, MA -- (Marketwired) -- 05/07/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the first quarter ended March 31, 2014. First Quarter Results Sales of the new OmniPod both in the U.S. and in international ... read more

Tuesday, May 6, 2014

Tuesday, April 29, 2014

Thursday, February 27, 2014

  • Insulet Reports Fourth Quarter and Full Year 2013 Results
    BEDFORD, MA -- (Marketwired) -- 02/27/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the fourth quarter and full year ended December 31, 2013. Fourth Quarter Results Fourth quarter 2013 revenue increased 19% to $68.5 million, ... read more

Thursday, February 13, 2014

Thursday, February 6, 2014

Tuesday, January 21, 2014

  • Insulet Appoints Patrick Ryan as Chief Operating Officer
    BEDFORD, MA -- (Marketwired) -- 01/21/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the appointment of Patrick Ryan as the Company's Chief Operating Officer. Mr. Ryan, a global supply chain expert and seasoned medical device executive, ... read more

Friday, January 3, 2014

Tuesday, December 10, 2013

  • Insulet Announces Commercial Agreement With Amgen
    BEDFORD, MA -- (Marketwired) -- 12/10/13 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced an agreement with Amgen Inc., the world's leading independent biotechnology company, for a five year commercial agreement to supply Amgen with ... read more